Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Cited by (717)

Items 601–700 of 717

1. A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine development
   Yifei Yuan, Xing Gao, Fengfeng Ni, Wenbo Xie, Wenbin Fu, Gaoxia Zhang, Huimin Hu, Yuncheng Li, Qinxue Hu, Chuanmengyuan Huang et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
2. Breakthrough SARS-CoV-2 infections in an eastern state of India: A preliminary report
   Girish Chandra Dash, Subhra Subhadra, Jyotirmayee Turuk, Debaprasad Parai, Sonalika Rath, Jyotsamayee Sabat, Usha Kiran Rout, Srikanta Kanungo, Hari Ram Choudhary, Rashmi Ranjan Nanda et al. · 2021 · Research Square
3. Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individuals
   Fabiola M. Moreno Echevarria, Mathew Caputo, Daniel M. Camp, Susheel Reddy, Chad J. Achenbach · 2024 · medRxiv
4. A High-Throughput Platform for Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution
   Yujie He, Zhenglin Yang, Yu-An Kuo, Yuting Wu, Diego Fonseca-Albert, Kyle K Le, Jeffrey G Guo, Yanxing Wang, Anh-Thu Nguyen, Yuan-I Chen et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
5. Fairer and healthier world for everyone – can lessons from the Dubrovnik Republic be applied to the COVID-19 pandemic?
   Marina Lukežić, Ozren Polašek · 2021 · Croatian Medical Journal
6. Clinical Features of Imported Chinese COVID-19 Patients Following Chinese Inactivated Vaccines Injection Abroad
   Jianwu Li, Na Jiang, Qing‐Lei Zeng, Yue Zhang, Yao Chu, Wenni Jin, Yi Liu, Wan Shi, Miao Sen Yang, Weihan He et al. · 2021 · Research Square
7. Screening for inhibitors of main protease in SARS-CoV-2: in silico and in vitro approach avoiding secondary amides
   Kazuki Z. Yamamoto, Nobuaki Yasuo, Masakazu Sekijima · 2021
8. Immunity to SARS-CoV-2 in a Dialyzed Patient Who Developed COVID-19 Twenty Days After the Second Dose of BNT162b2 Vaccine: a Case Report
   Sabrina Manni, Laurène Lotte, Antonin Bal, Laurence Josset, Bruno Lina, Mary‐Anne Trabaud, Grégory Destras, Bruno Pozzetto, Martine Valette, Corinne Passeron et al. · 2021 · Research Square
9. The Importance of Understanding COVID‐19–Related Hospitalizations
   Alon Vaisman · 2021 · Journal of Hospital Medicine
10. Viral and Immunological Characteristics of COVID-19 Vaccine Breakthrough Infections
    Takeshi Arashiro, Takayuki Kanno, Shô Miyamoto, S. Saito, Saya Moriyama, Tsuyoshi Sekizuka, Kazuhiko Kanou, Ashley Stucky, Shun Iida, Akira Ainai et al. · 2021 · Research Square
11. Broad neutralizing nanobody against SARS-CoV-2 engineered from pre-designed synthetic library
    Qian-Yun Liu, Chen-Guang Cai, Yanyan Huang, Li Zhou, Y. Guan, S. Fu, You-Hsuan Lin, Ting-rui Yang, Xiao-Hua Liang, Nan Wang et al. · 2021 · bioRxiv
12. Epidemiological Characteristics of Imported COVID-19 Cases, March to December 2020, Chengdu, China: Implication for Quarantine and Isolation of International Travelers
    Wenqiang Zhang, Yong Yue, Hu Min, Changhui Du, Cheng Wang, Xiaoli Tuo, Xiaoman Jiang, Shuangfeng Fan, Zhenhua Chen, Heng Chen et al. · 2021 · Research Square
13. Factors Associated with Low IgG Response to mRNA COVID-19 Vaccine BNT162b2
    Satoshi Sugawa, Masashi Nishimura, Shinichiro Ota, Miwa Morikawa, Takashi Sato, Masahiro Shinoda, Naoki Ishii, Kenichi Kamachi, Masaharu Shinkai · 2021 · Research Square
14. [Development of the hormonal reaction to stress in the ontogenesis of the baboon Papio hamadryas].
    V. Iu. Butnev, N P Goncharov · 1987 · PubMed
15. The Planning Mentality: Procedural and Normative Bases and Planning Tools.
    A. P. Johnston, Maureen E. Wilson · 1977 · Planning and changing
16. Yes, It Does
    Nathan W. Cummins · 2021 · Mayo Clinic Proceedings
17. Grippe et Covid-19
    Karim Jaffal, Hélène Mascitti · 2021 · Infectious Diseases Now
18. What did we learn from the SARS-CoV-2 vaccine breakthrough infections?
    Afra Shamnath, Mercy Rophina, Bani Jolly, Rahul C. Bhoyar, Sridhar Sivasubbu, Vinod Scaria · 2021
19. A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19
    Héctor M. Ramos‐Zaldívar, Karla G. Reyes-Perdomo, Nelson A. Espinoza‐Moreno, Ernesto Tomás Dox-Cruz, Thania Camila Aguirre Urbina, Astrid Yohaly Rivera Caballero, Eduardo Smelin Perdomo Domínguez, Sofía Guadalupe Peña Calix, Joselin Michelle Monterroso-Reyes, Erick Fernando Caballero Vásquez et al. · 2021 · medRxiv
20. What We Need to Do to Improve Our Immune System Despite the Use of Vaccination for COVID-19?
    Huang Wei Ling · 2021 · Biomedical Research and Clinical Reviews
21. The Chance of COVID-19 Infection after Vaccination
    Ghazaleh Khalili‐Tanha, Majid Khazaei, Saman Soleimanpour, Gordon A. Ferns, Amir Avan · 2022 · Infectious Disorders - Drug Targets
22. Comparison of the Clinical and Laboratory Findings and Outcomes of Hospitalized COVID-19 Patients who Were Vaccinated with Coronavac or Unvaccinated: An Analytical, Cross Sectional Study
    Serap Şimşek Yavuz, Gülşah Tunçer, Özlem Altuntaş Aydın, Mehtap Aydın, Filiz Pehlıvanoglu, Yeşim Tok, Sevim Meşe, Alper Gündüz, Ceyda Geyiktepe-Güçlü, İklima Özdoğan et al. · 2022 · Research Square
23. Información académica y pandemia
    Academia Nacional de Medicina. Venezuela, Rafael RANGEL-ALDAO · 2021 · ESPACIOS
24. SARS-CoV-2 Variants and Vaccines: Pledge to global response!
    Sushmita Roy, Bhuiyan Mohammad Mahtab Uddin, Iftikhar Ahmed · 2021 · Bangladesh Journal of Medical Microbiology
25. SARS-CoV-2 Variant Surveillance Using Tandem Targeted RT-PCR-based Genotyping Assays and Whole Genome Sequencing
    Nicholas P. Pinkhover, Eduardo Sanchez, Kerriann M. Pontbriand, Kenneth Okello, Liam M. Garvey, Kelli P. Fletcher, Alex Pum, Kurvin Li, Gabriel DeOliveira, Teddie Proctor et al. · 2022 · medRxiv
26. A Fast Extraction-Free Isothermal LAMP Assay for Detection of SARS-CoV-2 in Resource-Limited Settings
    Kathleen Gärtner, Harry Meleke, Mercy Kamdolozi, David Chaima, Lyson Samikwa, Mary Paynter, Maggie Nyirenda-Nyang’wa, Elaine Cloutman-Green, Eleni Nastouli, Nigel Jonathan Klein et al. · 2022 · Research Square
27. A diagnostic strategy for adjusting Covid-19 vaccination to individual immune state
    Anna Sabrina Kuechler, Sandra Weinhold, Fritz Boege, Ortwin Adams, Lisa Müller, Florian Babor, Sabrina Bianca Bennstein, Thi Xuan Uyen Pham, Maryam Hejazi, Sarah B. Reusing et al. · 2022 · Research Square
28. COVID-19 infection and vaccination status among health care workers in a tertiary care setting in Central Kerala
    Anitha Bhaskar, Sobha Akshayakumar, Asha Joan Murali, Vipin Sam Alexander · 2022 · International Journal of Community Medicine and Public Health
29. Clinical Features of SARS-COV-2 Infection After Full Vaccination in Health Care Workers of a COVID Hospital
    Donato Lacedonia, Giulia Scioscia, Giulio Giganti, Antonella Santoro, Pasquale Tondo, Maria Pia Foschino Barbaro · 2022 · Journal of Occupational and Environmental Medicine
30. SARS-Cov-2 Infection after Vaccination in Health Care Workers-Moffitt Cancer Center, Florida
    Chaudhary N, John Norman Greene · 2021 · Journal of Family Medicine
31. A case series of severe breakthrough infections observed in nine patients with COVID-19 in a southwestern German university hospital
    Bettina Lange, Sybille Welker, Maximilian Kittel, Claude Jabbour, Wolfgang Reindl, Thomas Walter, Alexandra Heininger · 2022 · Infection
32. Neuroimmunology and Neurological Manifestations of COVID-19
    Robert Weissert · 2022 · IntechOpen eBooks
33. Outbreak of delta variant SARS-CoV-2 virus on a psychogeriatric ward in Helsinki, Finland, August 2021: two-dose vaccination reduces mortality and disease severity amongst the elderly
    Adnan Malik, Laura Lehtola, Sanna Isosomppi, Teemu Smura, Jaana Saarenheimo, Veli-Jukka Anttila, Eeva Särelä · 2022 · Epidemiology and Infection
34. Time Series Analysis of COVID-19 Waves in India for Social Good
    Lakshmi Swarna Durga Nallam, Sindhu Sankati, Hiren Kumar Thakkar, Priyanka Singh · 2022 · Studies in computational intelligence
35. Epidemiological Characteristics of Imported COVID-19 Cases, March to December 2020, Chengdu, China: Implication for Quarantine and Isolation of International Travelers
    Wenqiang Zhang, Yong Yue, Hu Min, Changhui Du, Cheng Wang, Xiaoli Tuo, Xiaoman Jiang, Shuangfeng Fan, Zhenhua Chen, Heng Chen et al. · 2021 · Research Square
36. Vaccine Breakthrough Infections of SARS-Cov-2: A Case Report
    Ramprakash Kaswa · 2022 · Ethiopian Journal of Health Sciences
37. nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination
    Imran Shahid · 2022 · Dr Sulaiman Al Habib Medical Journal
38. Screening for inhibitors of main protease in SARS-CoV-2: in silico and in vitro approach avoiding secondary amides
    Kazuki Z. Yamamoto, Nobuaki Yasuo, Masakazu Sekijima · 2021
39. Coronaviruses Research in BRICS Countries
    Burtram Clinton Fielding, Georgia Schäfer · 2022 · MDPI eBooks
40. Explore the attitudes of children and adolescent parents towards the vaccination of COVID-19 in China
    Lin Wang, Wen Wen, Chen Chen, Jiake Tang, Chunyi Wang, Mengyun Zhou, Yongran Cheng, Xingwei Zhang, Mingwei Wang, Zhanhui Feng et al. · 2022 · Research Square
41. COVID-19 vaccine breakthrough infections among fully vaccinated Health Care Workers in Lagos, Nigeria
    David Ayoola Oladele, Abideen Oluwarotimi Salako, Ayorinde Babatunde James, Chika Kingsley Onwuamah, Olagoke Usman, Rufai Abubakar, Gideon Liboro, Oluwatosin Odubela, Sunday Mogaji, Fehintola Anthonia Ige et al. · 2022 · medRxiv
42. COVID-19 Vaccine Breakthrough Infections and Associated Factors in Kwekwe City, Zimbabwe, 2021
    Nyashadzashe Cosmas Makova, Mary Muchekeza, Addmore Chadambuka, Emmanuel Govha, Tsitsi Juru, Notion Tafara Gombe, Mufuta Tshimanga · 2022 · Open Journal of Epidemiology
43. Evaluation of Knowledge Attitude and Practices of Medical Undergraduate Students Towards COVID Vaccination
    Y. Sanjeeva Kumar Reddy, Manisha Jain, Rajni Gaind · 2021 · Indian Journal of Health Sciences and Care
44. Antibody avidity maturation favors SARS-CoV-2 convalescents over vaccinated individuals granting breadth in neutralizability and tolerance against variants
    Yu Nakagama, Katherine Candray, Natsuko Kaku, Yuko Komase, Maria-Virginia Rodriguez-Funes, Rhina Domínguez, Tomoya Tsuchida, Hiroyuki Kunishima, Etsuko Nagai, Eisuke Adachi et al. · 2022 · medRxiv
45. Assessment of SARS-CoV-2 vaccination status in SARS-COV-2 infected patients admitted in Dr Ruth K.M. Pfau, Civil Hospital Karachi
    Tazeen Rasheed, Faiza Sadaqat Ali, Bader Faiyaz Zuberi, Rabiah Sadaf · 2022 · Pakistan Journal of Medical Sciences
46. Clinical profile of ChAdOx1 nCoV-19- and BBV152-vaccinated individuals among hospitalized COVID-19 patients: a pair-matched study
    Vishakh C Keri, Bharathi Arunan, Parul Kodan, Manish Soneja, Neeraj Nischal, Ashwin Varadarajan, Akansha Didwania, Brunda RL, Anivita Aggarwal, Pankaj Jorwal et al. · 2022 · Therapeutic Advances in Vaccines and Immunotherapy
47. Surfing Corona waves – instead of breaking them: Rethinking the role of natural immunity in COVID-19 policy
    Andreas Kalk, Joachim Peter Sturmberg, Wim V. Damme, Garrett Wallace Brown, Valéry Ridde, Martin Zizi, Élisabeth Paul · 2022 · F1000Research
48. COVID-19 Infection After Vaccination Among Healthcare Workers at a Tertiary Level Health Care Center in Northern India: A Cross-Sectional Study
    Nandita Sharma, Mahendra Singh, Pradeep Aggarwal, Yogesh Arvind Bahurupi, Prasan Kumar Panda, Gaurika Saxena · 2022 · Recent Advances in Anti-Infective Drug Discovery
49. Peer Review #2 of "Rapid and convenient detection of SARS-CoV-2 using a colorimetric triple-target reverse transcription loop-mediated isothermal amplification method (v0.2)"
    2022 · PeerJ
50. Peer Review #3 of "Rapid and convenient detection of SARS-CoV-2 using a colorimetric triple-target reverse transcription loop-mediated isothermal amplification method (v0.1)"
    2022 · PeerJ
51. Peer Review #2 of "Rapid and convenient detection of SARS-CoV-2 using a colorimetric triple-target reverse transcription loop-mediated isothermal amplification method (v0.1)"
    2022 · PeerJ
52. Peer Review #1 of "Rapid and convenient detection of SARS-CoV-2 using a colorimetric triple-target reverse transcription loop-mediated isothermal amplification method (v0.1)"
    2022 · PeerJ
53. AI and the Clinical Immunology/Immunoinformatics for COVID-19
    Zikun Yang, Xiongye Xiao, Paul Bogdan · 2022 · Springer eBooks
54. SARS-CoV-2 Variants Distribution and Infections in Vaccinated and Unvaccinated Hospitalized Individuals in the Dominican Republic.
    Robert Paulino-Ramírez, Rita Alexandra Rojas-Fermin, Paula Cuevas, Leandro Tapia, Alejandro Vallejo Degaudenzi, Sayira Mueses, Victor Virgilio Calderón, Maridania Jabier, Anel E Guzman-Marte, Gilda Tolari et al. · 2023 · InterAmerican Journal of Medicine and Health
55. Assessing the Vaccine Efficacy in Health Care Providers for Combating the COVID-19 Infection: Results from Tertiary Cancer Care Centre
    Shalini Agnihotri, Anurag Mehta, Anurag Sharma · 2023 · COVID
56. Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine
    Anna Sabrina Kuechler, Eva Heger, Maike Wirtz, Sandra Weinhold, Markus Uhrberg, Fritz Boege, Karin Schulze-Bosse · 2023 · Vaccines
57. Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases
    Amir Emami, Fatemeh Javanmardi, Hamid Bakhtiari, Tahereh Rezaei, Abdolrasoul Hemmati, Ali Akbari, Neda Pirbonyeh · 2023 · Disaster Medicine and Public Health Preparedness
58. An Observational Study on Patients With COVID-19 Infection Admitted to the Intensive Care Unit With Respect to Their Vaccination Status
    Sounak Ghosh, Saswati D. Sinha, Mohua Bhattacharyya, Chandan Biswas, Subhash Kumar Todi, Rupak Kundu · 2023 · Cureus
59. Vaccine Basics and the Development and Rollout of COVID-19 Vaccines
    Subramani Mani, Daniel O. Griffin · 2023 · Elsevier eBooks
60. Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022
    Artur Zaczyński, Michał Hampel, Paweł Piątkiewicz, Jacek Nasiłowski, Sławomir Butkiewicz, Urszula Religioni, Agnieszka Barańska, Maria Malm, Agnieszka Neumann‐Podczaska, Régis Vaillancourt et al. · 2023 · Medical Science Monitor
61. ADVERSE EVENTS FOLLOWED BY COVID-19 VACCINATION AMONGST HEALTHCARE PROVIDERS
    Anjum Hameed, Asif Mehmood · 2022 · Pakistan Postgraduate Medical Journal
62. Vaccination and COVID-19 positivity rates in a network of eye hospitals in Southern and Eastern India during the second wave of COVID-19
    Rohit Khanna, Debananda Padhy, Asha Latha Mettla, Archana Bhargava, Savitri Sharma, Subhadra Jalali · 2023 · Indian Journal of Ophthalmology
63. Clinical features and outcomes of COVID-19 patients previously vaccinated with COVID vaccine
    Ramesh Maddimani, Ravi Krishnegowda, Kushal Yadav, Aishwarya Janaki, Sachin Katte Subramanya · 2023 · International Journal of Advances in Medicine
64. Coronavirus Vaccines
    Stanley M. Perlman, Mark R. Denison · 2023 · Elsevier eBooks
65. SARS-CoV-2 Variants and Vaccines: What We Learn and What We Can Forecast?
    Iftikhar Ahmed · 2021 · Journal of Enam Medical College
66. Tỷ lệ nhiễm SARS-CoV-2 sau tiêm vắc xin phòng COVID-19 tại tỉnh Bắc Ninh, Việt Nam, năm 2021
    Phạm Quang Lộc, Hoàng Thị Hải Vân, Đặng Thị Hương, Nguyễn Ngô Quang, Lê Minh Giang · 2023 · Tạp chí Nghiên cứu Y học
67. Surfing Corona waves – instead of breaking them: Rethinking the role of natural immunity in COVID-19 policy
    Andreas Kalk, Joachim Peter Sturmberg, Wim V. Damme, Garrett Wallace Brown, Valéry Ridde, Martin Zizi, Élisabeth Paul · 2023 · F1000Research
68. Research progress with the severe acute respiratory syndrome coronavirus 2 Delta variant
    Li Ai, Hong Zhou Lu · 2022 · Radiology of Infectious Diseases
69. COVID-19 Current Management and Strategies for Future Outlook
    Nayeema Khowser Shaik, Nalluri Poojitha, Kancharla Bhanu Sri Chandana, Maravajhala Vidyavathi, Sai Deepthi Rayadurgam Venkata · 2023 · International Journal of Pharmaceutical Investigation
70. COVID-19 ile enfekte sağlık çalışanlarında hastaneye yatış riskinin değerlendirilmesi
    Işıl Deniz Aliravci, Selçuk Kaya · 2023 · Troia Medical Journal
71. Examining the association of live virus neutralisation activity of capillary microsamples and risk of SARS-CoV-2 infections: a nested case control study within the Virus Watch community cohort
    Alexei Yavlinsky, Vincent Grigori Nguyen, Sarah Beale, Emma CB Wall, Mary Wu, Isobel Braithwaite, Jana Kovar, Madhumita Shrotri, Annalan M D Navaratnam, Wing Lam Erica Fong et al. · 2026 · Wellcome Open Research
72. Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern
    Nicholas P. Pinkhover, Kerriann M. Pontbriand, Kelli P. Fletcher, Eduardo Sanchez, Kenneth Okello, Liam M. Garvey, Alex Pum, Kurvin Li, Gabriel DeOliveira, Teddie Proctor et al. · 2024 · Microbiology Spectrum
73. Rapid Decline of SARS-CoV-2 Viral Load in Single vs. Double-Dose (Short-Interval <6 Weeks) ChAdOx nCoV-19 Vaccinated Health-Care Workers
    Arnab Ghosh, Poonam Kanta, Manisha Ramola, Ritin Mohindra, Kapil Goyal, Roop Kishore, Vikas Suri, P. V. M. Lakshmi, Chanderkanta Chauhan, Manisha Lakhanpal Sharma et al. · 2024 · Current Microbiology
74. Association between vaccination and days of hospitalization in adult patients with non-severe COVID-19
    Xiao Ding, Jiru Ye, Yao Tang, Feng Zhu · 2024 · The Journal of Infection in Developing Countries
75. Specific Mutations Identified in Patients Vaccinated and Infected with COVID-19 in Senegal
    Abdou Padane, Djibril Wade, Cyrille K. Diédhiou, Marièma Sarr, Seyni Ndiaye, Abdoulaye Souaré, M.M. Diop, Khadim Gueye, Marilyne Aza-Gnandji, Ndéye Diabou Diagne et al. · 2024 · Medical Research Archives
76. The Study of COVID-19 Infection in Health-Care Workers Post-COVID Vaccination
    Kirti Vinayak Kinge, Roshni Cynthia Miranda, Priyanka Dnyanoba Chate · 2024 · Journal of the Scientific Society
77. Bergenia purpurascens is a non-specific ACE2 inhibitor
    Yongxia Shi, Xiaoning Sun, Dalan Dai, Hongyu Guo, Lijuan Mei, Jun Dai, Zhaoxia Yu, Lei Jiang · 2024 · Research Square
78. Test positivity rate, contact history, and vaccination status of COVID-19 among patients visiting flu corner (fever clinic) of a tertiary care health center of Karnataka
    Sijin Wilson, Raghavendraswamy Koppad, Kanchana Nagendra, Sakshi Kumari, C. Liana, Ceethal Anna Joseph · 2023 · MRIMS Journal of Health Sciences
79. Research Progress on the Correlation Analysis between Reinfections of SARS-CoV-2 and Immunity
    佳宜 郭 · 2024 · Advances in Clinical Medicine
80. Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2
    Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, Hiroaki Takei, Yusuke Serizawa, Hidenori Takahashi, Mio Toyama‐Kousaka et al. · 2024 · Vaccine X
81. Correlation of Sars-Cov-2 IGG Antibody Levels with Viral Load Among Vaccine Breakthrough Infections: A Study From Rawalpindi
    Adnan Shahzad, Eijaz Ghani, Eisha Mansoor, Muhammad Ali Rathore, Saifullah Khan Niazi, Faraz Ahmed · 2024 · Pakistan Armed Forces Medical Journal
82. Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage
    Beatriz de Carvalho Marques, Cecília Ártico Banho, Lívia Sacchetto, Andréia Francesli Negri, Nikos Vasilakis, Maurício Lacerda Nogueira · 2024 · Viruses
83. Development and Implementation of a Comprehensive Initiative to Educate Healthcare Providers and Patients in the United States about the Risk of Drug-Drug Interactions Associated with Nirmatrelvir/ritonavir during the COVID-19 Pandemic
    Iqra Naz Arham, Donna R. Palumbo, Bharat D. Damle, Gurinder Singh Sidhu, Domenick Francis, Alejandro D. Cane, Lubna Merchant, Jamie Wilkins, Reema Mehta, Amanda Radola et al. · 2024 · Journal of Pharmaceutical Innovation
84. SVAIR: An Approach to Model COVID-19 with Vaccination
    Siddhartha Upadhyay, Soudeep Chowdhury, Krishanu Nath, Manas Kumar Bera · 2024 · International Conference on Control, Decision and Information Technologies (CoDIT)
85. Exploring the use of COVID-19 antigen rapid diagnostic tests among displaced populations in Iraq: findings from a pilot project in four IDP camps
    Lara Abou Ammar, Caitlin M. Wolfe, Lamiaa Nagib, Mohammed Slebei, Sezan Shawkat, Dilman Amo, Raveen Abdullah, Rawshan Abdulmalik, H. Amin, Huda Shafiq et al. · 2024 · Conflict and Health
86. Gambaran Klinis COVID-19 pada Mahasiswa FK Universitas Andalas Berdasarkan Status Vaksinasi COVID-19
    Rayhendra Hanif, Netti Suharti, Rosfita Rasyid, Andani Eka Putra, Russilawati Russilawati, Amirah Zatil Izzah · 2024 · Jurnal Ilmu Kesehatan Indonesia
87. Investigation on the Inhibitory Effect of Bergenia purpurascens Water Extract on COVID-19 XBB1.5 Variant and Its Blocking ACE2 Mechanism
    Yongxia Shi, Xiaoning Sun, Zhaoxia Yu, Dalan Dai, Hongyu Guo, Lijuan Mei, Jun Dai, Lei Jiang · 2025 · Natural Product Communications
88. Critical illness in immunocompromised patients: insights into relapse or persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): case series report
    Olga Hernández, Juan Felipe Llano, Ana Milena Sánchez, Fabian Alberto Jaimes, A. Melissa Moreno, Laura S. Perez‐Restrepo, Jaime Úsuga, Erwin Camacho, Jorge E. Osorio, Juan Pablo Hernandez-Ortiz · 2025 · Journal of Medical Case Reports
89. Can people vaccinated against COVID-19 still spread the coronavirus?
    Sanjay Mishra · 2021 · The Conversation
90. What is a breakthrough infection? 6 questions answered about catching COVID-19 after vaccination
    Sanjay Mishra · 2021
91. Single dose alum adjuvanted RBD protein vaccine provides protection against homologous challenge with SARS-CoV-2 Washington strain and heterologous rechallenge with Delta and Omicron BA.5 variants in K18 hACE2 mouse model
    Rajesh Thippeshappa, Viraj Kulkarni, Varun Dwivedi, Jennifer McMillian, Marco Argonza, Joshua Castro, Oscar L. Rodriguez, Billie Maingot, Michal Gaži, Reagan J. Meredith et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
92. Neutralization and Anti‐S Antibody Titers in SARS‐CoV‐2 Boosted Adults in Mexico: A Comparison Across Five Vaccine Types
    Nabetse Baruc Blas-Miranda, Martha Carnalla, Ana Cristina Basto-Abreu, Jesús Martínez-Barnetche, Celia Mercedes Alpuche-Aranda, Carlos Gaspar-Castillo, Rodrigo Aparicio‐Antonio, Jisela Dimas-González, Irma López-Martínez, Nayeli Estefanía Sánchez-Casiano et al. · 2025 · International Journal of Microbiology
93. Additional file 1 of Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon
    Habib Alkalamouni, Farouk F. Abou Hassan, Mirna Bou Hamdan, Andrew J. Page, Martin C. Lott, Matthews, Michaela, Nada Ghosn, Alissar Rady, Rami A. Mahfouz, George Farah Araj et al. · 2023 · Figshare
94. Additional file 6 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
    Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
95. Additional file 1 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
    Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
96. Additional file 4 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
    Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
97. Additional file 7 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
    Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
98. Additional file 2 of Immunogenicity and safety of COVID-19 BNT162b2 booster vaccine in end-stage kidney disease patients receiving haemodialysis in Yogyakarta, Indonesia: a cohort prospective study
    Metalia Puspitasari, Prenali Dwisthi Sattwika, Auliana R. P. Hidayat, Wijaya, Wynne, Yulia Wardhani, Umi Solekhah Intansari, Nyoman Kertia, Purwanto, Bambang, Jarir At Thobari · 2023 · Figshare
99. Additional file 1 of Lessons drawn from Shanghai for controlling highly transmissible SARS-CoV-2 variants: insights from a modelling study
    Wang, Hao, Tangjuan Li, Gao, Huan, Huang, Chenxi, Tang, Biao, 唐三一, Robert Cheke, Weike Zhou · 2023 · Figshare
100. Additional file 2 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
     Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang, Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare